0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Spasticity - Pipeline Insight, 2025 - Product Thumbnail Image

Spasticity - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 106 Pages
  • Global
From
EUR$2,000USDGBP
Progressive Multifocal Leukoencephalopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Progressive Multifocal Leukoencephalopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Primary Progressive Multiple Sclerosis- Pipeline Insight, 2025 - Product Thumbnail Image

Primary Progressive Multiple Sclerosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
GABAA Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

GABAA Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
GABA Receptor Modulators - Pipeline Insight, 2025 - Product Thumbnail Image

GABA Receptor Modulators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Narcolepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Narcolepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
EUR$2,000USDGBP
Partial Seizure - Pipeline Insight, 2025 - Product Thumbnail Image

Partial Seizure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Neurofibromatoses - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibromatoses - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Nrf2 Pathway Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Nrf2 Pathway Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Peripheral Neuropathic Pain-Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral Neuropathic Pain-Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Hypersomnia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypersomnia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025 - Product Thumbnail Image

Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
Amyloid Protein Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Protein Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,250USDGBP
From
EUR$1,250USDGBP
Brain Hemorrhage - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
EUR$1,500USDGBP
Fatigue - Pipeline Insight, 2025 - Product Thumbnail Image

Fatigue - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$2,000USDGBP
Fragile X Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Fragile X Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
From
EUR$2,000USDGBP
Progressive Supranuclear Palsy- Pipeline Insight, 2025 - Product Thumbnail Image

Progressive Supranuclear Palsy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more